Thirty years of the human immunodeficiency virus epidemic and beyond.
10.1038/ijos.2013.76
- Author:
Fariba S YOUNAI
- Publication Type:Journal Article
- MeSH:
Anti-Retroviral Agents;
therapeutic use;
Antiretroviral Therapy, Highly Active;
HIV;
pathogenicity;
HIV Infections;
drug therapy;
prevention & control;
transmission;
Humans
- From:
International Journal of Oral Science
2013;5(4):191-199
- CountryChina
- Language:English
-
Abstract:
After more than 30 years of battling a global epidemic, the prospect of eliminating human immunodeficiency virus (HIV) as the most challenging infectious disease of the modern era is within our reach. Major scientific discoveries about the virus responsible for this immunodeficiency disease state, including its pathogenesis, transmission patterns and clinical course, have led to the development of potent antiretroviral drugs that offer great hopes in HIV treatment and prevention. Although these agents and many others still in development and testing are capable of effectively suppressing viral replication and survival, the medical management of HIV infection at the individual and the population levels remains challenging. Timely initiation of antiretroviral drugs, adherence to the appropriate therapeutic regimens, effective use of these agents in the pre and post-exposure prophylaxis contexts, treatment of comorbid conditions and addressing social and psychological factors involved in the care of individuals continue to be important considerations.
